The effect of psychostimulants on [3H]dopamine uptake and release in rat brain synaptic vesicles

Journal of Neural Transmission

Volumn 113, Issue 9, 2006, Pages 1347-1352

  Schwartz, K ^a   Weizman, A ^a   Rehavi, M ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

D amphetamine; Fenfluramine; Methylendioxymethamphetamine; Neurotoxicity; Parachloroamphetamine; Psychostimulants; Vesicular Monoamine Transporter (VMAT2)

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; CHLORAMPHETAMINE; DEXAMPHETAMINE; DIHYDROTETRABENAZINE; DOPAMINE; FENFLURAMINE; PSYCHOSTIMULANT AGENT; VESICULAR MONOAMINE TRANSPORTER 2; CENTRAL STIMULANT AGENT; DOPAMINE UPTAKE INHIBITOR; SLC18A2 PROTEIN, RAT; VESICULAR MONOAMINE TRANSPORTER;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINE UPTAKE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; RAT; SYNAPSE VESICLE; ANIMAL; BRAIN LEVEL; DRUG EFFECT; IN VITRO STUDY; KINETICS; METABOLISM; NEOSTRIATUM;

ANIMALS; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; KINETICS; NEOSTRIATUM; RATS; SYNAPTIC VESICLES; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 33747881501     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-005-0383-4     Document Type: Article

References (16)

1. MI Colado AR Green 1994 A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds Br J Pharmacol 111 131 136
2. JF Fischer AK Cho 1979 Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model J Pharmacol Exp Ther 208 203 209
3. 3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine Biochem Pharmacol 31 983 992
4. G Rudnick SS Steiner-Mordoch H Fishkes Y Stern-Bach S Schuldiner 1990 Energetics of reserpine binding and occlusion by the chromaffin granule biogenic amine transporter Biochemistry 29 603 608
5. G Rudnick SC Wall 1992 The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release Proc Natl Acad Sci USA 89 1817 1821
6. V Sandoval EL Riddle GR Hanson AE Fleckenstein 2003 Methylphenidate alters vesicular monoamine transport and prevents methamphetmine-induced dopaminergic deficits J Pharmacol Exp Ther 304 1181 1187
7. D Scherman 1986 Dihydrotetrabenazine binding and monoamine uptake in mouse brain regions J Neurochem 47 331 339
8. S Schuldiner 1994 A molecular glimpse of vesicular monoamine transporters J Neurochem 62 2067 2078
9. S Schuldiner A Shirvan M Linial 1995 Vesicular neurotransmitter transporters: from bacteria to humans Physiol Rev 75 369 392
10. S Schuldiner S Steiner-Mordoch R Yelin SC Wall G Rudnick 1993 Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters Mol Pharmacol 44 1227 1231
11. JE Sprague MP Johnson CJ Schmidt DE Nichols 1996 Studies on the mechanism of p-chloroamphetamine neurotoxicity Biochem Pharmacol 52 1271 1277
12. D Sulzer NT Maidment S Rayport 1993 Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons J Neurochem 60 527 535
13. D Sulzer S Rayport 1990 Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action Neuron 5 797 808
14. 2+-ATPase and a pH gradient in the storage of catecholamines in synaptic vesicles Biochemistry 17 2517 2523
15. JA Weaver JD Deupree 1982 Conditions required for reserpine binding to the catecholamine transporter on chromaffin granule ghosts Eur J Pharmacol 80 437 438
16. J Yuan U [tmp] McCann G Ricaurte 1997 Methylphenidate and brain dopamine neurotoxicity Brain Res 767 172 175